Interaction of chemokine receptor CCR5 with its ligands: Multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding

Journal of Experimental Medicine

Volumn 186, Issue 8, 1997, Pages 1373-1381

  Wu, Lijun ^a   LaRosa, Greg ^a   Kassam, Nasim ^a   Gordon, Cynthia J ^b   Heath, Heidi ^a   Ruffing, Nancy ^a   Chen, Howard ^a   Humblias, Jason ^a   Samson, Michel ^c   Parmentier, Marc ^c   Moore, John P ^b   Mackay, Charles R ^a  

^a MILLENNIUM PHARMACEUTICALS INC   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CD3 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; GLYCOPROTEIN GP 120; LIGAND; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCLONAL ANTIBODY; RANTES;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CHEMOTAXIS; CHIMERA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BINDING, COMPETITIVE; CHEMOKINES, CC; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; LIGANDS; LYMPHOMA, T-CELL; MACROPHAGE INFLAMMATORY PROTEIN-1; MICE; MICE, INBRED C57BL; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RANTES; RECEPTORS, CCR5; TUMOR CELLS, CULTURED;

EID: 0030779808     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.8.1373     Document Type: Article

References (54)

1. Baggiolini, M., B. Dewald, and B. Moser. 1994. IL-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55:97-179.
2. Oppenheim, J.J., C.O. Zachariae, N. Mukaida, and K. Matsushima. 1991. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9: 617-648.
3. Miller, M.D., and M.S. Krangel. 1992. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit. Rev. Immunol. 12:17-46.
4. Jose, P.J., D.A. Griffiths-Johnson, P.D. Collins, D.T. Walsh, R. Moqbel, N.F. Totty, O. Truong, J.J. Hsuan, and T.J. Williams. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179:881-887.
5. Ponath, P.D., S. Qin, D.J. Ringler, I. Clark-Lewis, J. Wang, N. Kassam, H. Smith, X. Shi, J.-A. Gonzalo, W. Newman, et al. 1996. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties provide a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97:604-612.
6. Murphy, P.M. 1994. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12:593-633.
7. Schall, T.J., and K.B. Bacon. 1994. Chemokines, leukocyte trafficking, and inflammation. Curr. Opin. Immunol. 6:865-873.
8. Gerard, C., and N.P. Gerard. 1994. The pro-inflammatory seven-transmembrane segment receptors of the leukocyte. Curr. Opin. Immunol. 6:140-145.
9. Mackay, C.R. 1997. What chemokine is that? Curr. Biol. In press.
10. Ponath, P.D., S. Qin, T.W. Post, J. Wang, L. Wu, N.P. Gerard, W. Newman, C. Gerard, and C.R. Mackay. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183: 2437-2448.
11. Broaddus, V.C., A.M. Boylan, J.M. Hoeffel, K.J. Kim, M. Sadick, A. Chuntharapai, and C.A. Hebert. 1994. Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. J. Immunol. 152:2960-2967.
12. Mulligan, M.S., M.L. Jones, M.A. Bolanowski, M.P. Baganoff, C.L. Deppeler, D.M. Meyers, U.S. Ryan, and P.A. Ward. 1993. Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. J. Immunol. 150:5585-5595.
13. Sekido, N., N. Mukaida, A. Harada, I. Nakanishi, Y. Watanabe, and K. Matsushima. 1993. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature (Lond.). 365:654-657.
14. Heath, H., S. Qin, P. Rao, L. Wu, G. LaRosa, N. Kassam, P.D. Ponath, and C.R. Mackay. 1997. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J. Clin. Invest. 99:178-184.
15. Qin, S., G. LaRosa, J.J. Campbell, H. Smith-Heath, N. Kassam, X. Shi, L. Zeng, E.C. Butcher, and C.R. Mackay. 1996. Expression of monocyte chemoattractant protein-1 and interleukm-8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential. Eur. J. Immunol. 26: 640-647.
16. Taub, D.D., A.R. Lloyd, K. Conlon, J.M. Wang, J.R. Ortaldo, A. Harada, K. Matsushima, D.J. Kelvin, and J.J. Oppenheim. 1993. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177:1809-1814.
17. Taub, D.D., P. Proost, W.J. Murphy, M. Anver, D.L. Longo, J. van Damme, and J.J. Oppenheim. 1995. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J. Clin. Invest. 95:1370-1376.
18. Schall, T.J., K. Bacon, K.J. Toy, and D.V. Goeddel. 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature (Lond.). 347:669-671.
19. Wu, L., W.A. Paxton, N. Kassam, N. Ruffing, J.B. Rottman, N. Sullivan, H. Choe, J. Sodroski, W. Newman, R.A. Koup, and C.R. Mackay. 1997. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J. Exp. Med. 185:1681-1691.
20. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P.D. Ponath, L. Wu, C.R. Mackay, G. LaRosa, W. Newman, et al. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 85:1135-1148.
21. Alkhatib, G., C. Combadière, C.C. Broder, Y. Feng, P.E. Kennedy, P.M. Murphy, and E.A. Berger. 1996. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science (Wash. DC). 272: 1955-1958.
22. Doranz, B.J., J. Rucker, Y. Yi, R.J. Smyth, M. Samson, S.C. Peiper, M. Parmentier, R.G. Collman, and R.W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokme receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 85:1149-1158.
23. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R.E. Sutton, C.M. Hill, et al. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature (Lond.). 381:661-666.
24. + cells is mediated by the chemokine receptor CC-CKR-5. Nature (Lond.). 381:667-673.
25. Feng, Y., C.C. Broder, P.E. Kennedy, and E.A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science (Wash. DC). 272:872-877.
26. Wu, L., N. Gerard, R. Wyatt, H. Choe, C. Parolin, N. Ruffing, A. Borsetti, A.A. Cardoso, E. Desjardin, W. Newman, et al. 1996. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature (Lond.). 384:179-183.
27. Trkola, A., T. Dragic, J. Arthos, J.M. Binley, W.C. Olson, G.P. Allaway, C. Cheng-Mayer, J. Robinson, P.J. Maddon, and J.P. Moore. 1996. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR5. Nature (Lond.). 384:184-186.
28. Lapham, C.K., J. Ouyang, B. Chandrasekhar, N.Y. Nguyen, D.S. Dimitrov, and H. Golding. 1996. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science (Lond.). 274:602-605.
29. Liu, R., W.A. Paxton, S. Choe, D. Ceradini, S.R. Martin, R. Horuk, M.E. MacDonald, H. Stuhlmann, R.A. Koup, and N.R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance ot some multiply-exposed individuals to HIV-1 infection. Cell. 86:367-377.
30. Samson, M., F. Libert, B.J. Doranz, J. Rucker, C. Liesnard, C.M. Farber, S. Saragosti, C. Lapoumeroulie, J. Cognaux, C. Forceille, et al. 1996. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (Lond.). 382:722-725.
31. Dean, M., M. Carrington, C. Winkler, G.A. Huttley, M.W. Smith, R. Allikmets, J.J. Goedert, S.P. Buchbinder, E. Vittinghoff, E. Gomperts, et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science (Wash. DC). 273:1856-1862.
32. Huang, Y., W.A. Paxton, S.M. Wolinsky, A.U. Neumann, L. Zhang, T. He, S. Kang, D. Ceradini, Z. Jin, K. Yazdanbakhsh, et al. 1996. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2: 1240-1243.
33. Paxton, W.A., S.R. Martin, D. Tse, T.R. O'Brien, J. Skurnick, N.L. VanDevanter, N. Padian, J.F. Braun, D.P. Kotler, S.M. Wolinsky, and R.A. Koup. 1996. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat. Med. 2:412-417.
34. Cohen, J. 1997. Exploiting the HIV-chemokine nexus. Science (Wash. DC). 275:1261-1264.
35. Rucker, J., M. Samson, B.J. Doranz, F. Libert, J.F. Berson, Y. Yi, R.J. Smyth, R.G. Collman, G.G. Broder, G. Vassart, et al. 1996. Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell. 87: 437-446.
36. Atchison, R.E., J. Gosling, F.S. Monteclaro, C. Franci, L. Digilio, I.F. Charo, and M.A. Goldsmith. 1996. Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science (Wash. DC). 274:1924-1926.
37. Farzan, M., H. Ghoe, K.A. Martin, Y. Sun, M. Sidelko, C.R. Mackay, W. Newman, N.P. Gerard, J. Sodroski, and C. Gerard. 1997. HIV-1 entry and macrophage inflammatory protein-1β-mediated signaling are independent functions of the chemokine receptor CCR5. J. Biol. Chem. 272:6854-6857.
38. Bieniasz, P.D., R.A. Fridell, I. Aramori, S.S.G. Ferguson, M.G. Caron, and B.R. Cullen. 1997. HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 coreceptor. EMBO (Eur. Mol. Biol. Organ.) J. 16:2599-2609.
39. Gosling, J., F.S. Monteclaro, R.E. Atchison, H. Arai, C. Tsou, M.A. Goldsmith, and I.F. Charo. 1997. Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc. Natl. Acad. Sci. USA. 94:5061-5066.
40. Lu, Z.H., J.F. Berson, Y.H. Chen, J.D. Turner, T.Y. Zhang, M. Sharron, M.H. Jenks, Z.X. Wang, J. Kim, J. Rucker, et al. 1997. Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains. Proc. Natl. Acad. Sci. USA. 94:6426-6431.
41. Ghattas, I.R., J.R. Sanes, and J.E. Majors. 1991. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression ot two genes from a recombinant provirus in cultured cells and in embryos. Mol. Cell. Biol. 11:5848-5859.
42. Perret, J., M. Ludgate, F. Libert, C. Gerard, J.E. Dumont, G. Vassart, and M. Parmentier. 1990. Stable expression of the human TSH receptor in CHO cells and characterization of differentially expressing clones. Biochem. Biophys. Res. Commun. 17:1044-1050.
43. Van Riper, G., S. Siciliano, P.A. Fischer, R. Meurer, M.S. Springer, and H. Rosen. 1993. Characterization and species distribution of high affinity GTP-coupled receptors for human rantes and monocyte chemoattractant protein 1. J. Exp. Med. 177:851-856.
44. Endres, M.J., P.R. Clapham, M. Marsh, M. Ahuja, J.D. Turner, A. McKnight, J.F. Thomas, D. Stoebenau-Haggarty, S. Choc, P.J. Vance, et al. 1996. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell. 87:745-756.
45. Wu, L., N. Ruffing, X. Shi, W. Newman, D. Soler, C.R. Mackay, and S. Qin. 1996. Discrete steps in binding and signaling of interleukin-8 with its receptor. J. Biol. Chem. 271: 31202-31209.
46. Connor, R.I., B.K. Chen, S. Choc, and N.R. Landau. 1995. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 206:935-944.
47. Hill, C.M., H.-K. Deng, D. Unutmaz, V. Kewalramani, L. Bastiani, S. Zolla-Pazner, and D.R. Littman. 1997. Envelope glycoproteins from HIV-1, HIV-2, and SIV can use human CCR5 as a cofactor for viral entry and make direct CD4-dependent interactions with this chemokine receptor. J. Virol. 71:6296-6304.
48. Bleul, C.C., L. Wu, J.A. Hoxie, T.A. Springer, and C.R. Mackay. 1997. The chemokine receptors CXCR4 and CCR5 are differentially expressed and regulated on T cells. Proc. Natl. Acad. Sci. USA. 94:1925-1930.
49. + T cells. Science (Wash. DC). 270:1811-1815.
50. Simmons, G., P.R. Clapham, L. Picard, R.E. Offord, M.M. Rosenkilde, T.W. Schwartz, R. Buser, T.N.C. Wells, and A.E.I. Proudfoot. 1997. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science (Wash. DC). 276:276-279.
51. Arenzana-Seisdedos, F., J.L. Virelizier, D. Rousset, I. Clark-Lewis, P. Loetscher, B. Moser, and M. Baggiolini. 1996. HIV blocked by chemokine antagonist. Science (Wash. DC). 383:400.
52. 51a. Samson, M., G. LaRosa, F. Libert, M. Detheux, P. Paindavoine, G. Vassart, and M. Parmentier. 1997. The second extracellular loop of CCR5 is the major determinant of ligand specificity. J. Biol. Chem. In press.
53. Mackay, C.R. 1996. Chemokine receptors and T cell chemotaxis. J. Exp. Med. 184:799-802.
54. Roth, S.J., M.W. Carr, and T.A. Springer. 1995. C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-γ-inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes. Eur. J. Immunol. 25:3482-3488.